臨床開発

細胞療法を進展させる臨床試験

One of our principal tasks is to design and coordinate clinical studies to test the therapeutic utility of Miltenyi Biotec’s clinical products in areas such as regenerative medicine and stem cell therapy, with an emphasis on hemato-oncological, infectious, and cancer immunotherapy. Novel adsorbers for immune apheresis are also developed by the clinical development department. Working with many internationally recognized professionals in centers throughout the world, we carry out a number of trials that range from safety/feasibility (phase I/II) to pivotal stage (phase III) and post-market surveillance trials. Additionally, our products are used in independent academic trials in the above mentioned therapeutic areas.